MAP3K19	NN	MAP3K19 NN PennPOS
Is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
Novel	JJ	novel JJ PennPOS
Regulator	NNP	regulator NN PennPOS
of	IN	of pp-f NUPOS
TGF-b	NNP	TGF-b NNP PennPOS
Signaling	NN	signaling NN PennPOS
That	WDT	That WDT PennPOS
Impacts	VBZ	impact VBZ PennPOS
Bleomycin-Induced	JJ	bleomycin-induced JJ PennPOS
Lung	NN	lung NN PennPOS
Injury	NNP	injury NN PennPOS
and	CC	and cc NUPOS
Pulmonary	NNP	Pulmonary NNP PennPOS
Fibrosis	NNP	fibrosis NN PennPOS
.	.	. . NUPOS

UNASSIGNED	NNP	UNASSIGNED NNP PennPOS
:	:	: : NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
progressive	JJ	progressive JJ PennPOS
,	,	, , NUPOS
debilitating	JJ	debilitating JJ PennPOS
disease	NN	disease NN PennPOS
for	IN	for c-acp NUPOS
which	WDT	which r-crq NUPOS
two	CD	two crd NUPOS
medications	NNS	medication NNS PennPOS
,	,	, , NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
and	CC	and cc NUPOS
nintedanib	NN	nintedanib NN PennPOS
,	,	, , NUPOS
have	VBP	have vhb NUPOS
only	RB	only av-j NUPOS
recently	RB	recent av-j NUPOS
been	VBN	be vbn NUPOS
approved	VBN	approve vvn NUPOS
for	IN	for c-acp NUPOS
treatment	NN	treatment NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
cytokine	NN	cytokine NN PennPOS
TGF-b	NN	TGF-b NN PennPOS
has	VBZ	have vdz NUPOS
been	VBN	be vbn NUPOS
shown	VBN	show VBN PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
a	DT	a dt NUPOS
central	JJ	central JJ PennPOS
mediator	NN	mediator NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
disease	NN	disease NN PennPOS
process	NN	process NN PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
investigated	VBD	investigate VBD PennPOS
the	DT	the dt NUPOS
role	NN	role NN PennPOS
of	IN	of pp-f NUPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
kinase	NN	kinase NN PennPOS
,	,	, , NUPOS
MAP3K19	NN	MAP3K19 NN PennPOS
,	,	, , NUPOS
upregulated	VBN	upregulate VBN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
tissue	NN	tissue NN PennPOS
,	,	, , NUPOS
in	IN	in IN PennPOS
TGF-b-induced	JJ	tgf-b-induced JJ PennPOS
signal	NN	signal NN PennPOS
transduction	NN	transduction NN PennPOS
and	CC	and cc NUPOS
in	IN	in IN PennPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

MAP3K19	NN	MAP3K19 NN PennPOS
has	VBZ	have vdz NUPOS
a	DT	a dt NUPOS
very	RB	very av NUPOS
limited	JJ	limited JJ PennPOS
tissue	NN	tissue NN PennPOS
expression	NN	expression NN PennPOS
,	,	, , NUPOS
restricted	JJ	restricted JJ PennPOS
primarily	RB	primary RB PennPOS
to	TO	to p-acp NUPOS
the	DT	the dt NUPOS
lungs	NNS	lung NNS PennPOS
and	CC	and cc NUPOS
trachea	NN	trachea NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
tissue	NN	tissue NN PennPOS
,	,	, , NUPOS
expression	NN	expression NN PennPOS
was	VBD	be vbd NUPOS
predominantly	RB	predominant RB PennPOS
localized	JJ	localized JJ PennPOS
to	TO	to p-acp NUPOS
alveolar	JJ	alveolar JJ PennPOS
and	CC	and cc NUPOS
interstitial	JJ	interstitial JJ PennPOS
macrophages	NNS	macrophage NNS PennPOS
,	,	, , NUPOS
bronchial	JJ	bronchial JJ PennPOS
epithelial	JJ	epithelial JJ PennPOS
cells	NNS	cell NNS PennPOS
and	CC	and cc NUPOS
type	NN	type NN PennPOS
II	CD	II crd NUPOS
pneumocytes	NNS	pneumocyte NNS PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
epithelium	NN	epithelium NN PennPOS
.	.	. . NUPOS

MAP3K19	NN	MAP3K19 NN PennPOS
was	VBD	be vbd NUPOS
also	RB	also av NUPOS
found	VBN	find VBN PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
overexpressed	VBN	overexpress VBN PennPOS
in	IN	in IN PennPOS
bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
macrophages	NNS	macrophage NNS PennPOS
from	IN	from pp NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
compared	VBN	compare VBN PennPOS
to	TO	to p-acp NUPOS
normal	JJ	normal JJ PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

Treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
A549	NN	A549 NN PennPOS
or	CC	or cc NUPOS
THP-1	NN	THP-1 NN PennPOS
cells	NNS	cell NNS PennPOS
with	IN	with pp NUPOS
either	CC	either CC PennPOS
MAP3K19	NN	MAP3K19 NN PennPOS
siRNA	NN	siRNA NN PennPOS
or	CC	or cc NUPOS
a	DT	a dt NUPOS
highly	RB	high av-j NUPOS
potent	JJ	potent JJ PennPOS
and	CC	and cc NUPOS
specific	JJ	specific JJ PennPOS
inhibitor	NN	inhibitor NN PennPOS
reduced	VBD	reduce VBD PennPOS
phospho-Smad2	NN	phospho-Smad2 NN PennPOS
CD	cd NN PennPOS
3	CD	3 crd NUPOS
nuclear	JJ	nuclear JJ PennPOS
translocation	NN	translocation NN PennPOS
following	VBG	follow VBG PennPOS
TGF-b	NN	TGF-b NN PennPOS
stimulation	NN	stimulation NN PennPOS
.	.	. . NUPOS

TGF-b-induced	JJ	tgf-b-induced JJ PennPOS
gene	NN	gene NN PennPOS
transcription	NN	transcription NN PennPOS
was	VBD	be vbd NUPOS
also	RB	also av NUPOS
strongly	RB	strong av-j NUPOS
inhibited	VBN	inhibit VBN PennPOS
by	IN	by IN PennPOS
both	CC	both CC PennPOS
the	DT	the dt NUPOS
MAP3K19	NN	MAP3K19 NN PennPOS
inhibitor	NN	inhibitor NN PennPOS
and	CC	and cc NUPOS
nintedanib	NN	nintedanib NN PennPOS
,	,	, , NUPOS
whereas	IN	whereas cs NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
had	VBD	have vhd NUPOS
a	DT	a dt NUPOS
much	RB	much RB PennPOS
less	RBR	little RBR PennPOS
pronounced	JJ	pronounced JJ PennPOS
effect	NN	effect NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
combination	NN	combination NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
MAP3K19	NN	MAP3K19 NN PennPOS
inhibitor	NN	inhibitor NN PennPOS
appeared	VBD	appear VBD PennPOS
to	TO	to p-acp NUPOS
act	VB	act VBP PennPOS
synergistically	RB	synergistic av-j NUPOS
with	IN	with pp NUPOS
either	CC	either CC PennPOS
pirfenidone	NN	pirfenidone NN PennPOS
or	CC	or cc NUPOS
nintedanib	NN	nintedanib NN PennPOS
,	,	, , NUPOS
at	IN	at pp NUPOS
the	DT	the dt NUPOS
level	NN	level NN PennPOS
of	IN	of pp-f NUPOS
target	NN	target NN PennPOS
gene	NN	gene NN PennPOS
transcription	NN	transcription NN PennPOS
or	CC	or cc NUPOS
protein	NN	protein NN PennPOS
production	NN	production NN PennPOS
.	.	. . NUPOS

Finally	RB	final av-j NUPOS
,	,	, , NUPOS
in	IN	in IN PennPOS
an	DT	a dt NUPOS
animal	NN	animal NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
inhibition	NN	inhibition NN PennPOS
of	IN	of pp-f NUPOS
MAP3K19	NN	MAP3K19 NN PennPOS
strongly	RB	strong av-j NUPOS
attenuated	VBD	attenuate VBD PennPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
when	WRB	when c-crq NUPOS
administered	VBN	administer VBN PennPOS
either	CC	either CC PennPOS
prophylactically	RB	prophylactical RB PennPOS
ortherapeutically	RB	ortherapeutical RB PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
summary	NN	summary NN PennPOS
,	,	, , NUPOS
these	DT	these d NUPOS
results	NNS	result NNS PennPOS
strongly	RB	strong av-j NUPOS
suggest	VBP	suggest VBP PennPOS
that	IN	that cst NUPOS
inhibition	NN	inhibition NN PennPOS
of	IN	of pp-f NUPOS
MAP3K19	NN	MAP3K19 NN PennPOS
may	MD	may vmb NUPOS
have	VB	have vhi NUPOS
a	DT	a dt NUPOS
beneficial	JJ	beneficial JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
effect	NN	effect NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
and	CC	and cc NUPOS
represents	VBZ	represent VBZ PennPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
strategy	NN	strategy NN PennPOS
to	TO	to p-acp NUPOS
target	VB	target VBP PennPOS
this	DT	this d NUPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

